Full text
PDF

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Crewe H. K., Lennard M. S., Tucker G. T., Woods F. R., Haddock R. E. The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes. Br J Clin Pharmacol. 1992 Sep;34(3):262–265. doi: 10.1111/j.1365-2125.1992.tb04134.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Diot P., Jonville A. P., Gerard F., Bonnelle M., Autret E., Breteau M., Lemarie E., Lavandier M. Possible interaction entre théophylline et fluvoxamine. Therapie. 1991 Mar-Apr;46(2):170–171. [PubMed] [Google Scholar]
- Jonkman J. H., Upton R. A. Pharmacokinetic drug interactions with theophylline. Clin Pharmacokinet. 1984 Jul-Aug;9(4):309–334. doi: 10.2165/00003088-198409040-00002. [DOI] [PubMed] [Google Scholar]
- Schwartz J., Jauregui L., Lettieri J., Bachmann K. Impact of ciprofloxacin on theophylline clearance and steady-state concentrations in serum. Antimicrob Agents Chemother. 1988 Jan;32(1):75–77. doi: 10.1128/aac.32.1.75. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sherrill D. L., Lebowitz M. D., Burrows B. Epidemiology of chronic obstructive pulmonary disease. Clin Chest Med. 1990 Sep;11(3):375–387. [PubMed] [Google Scholar]
- Sperber A. D. Toxic interaction between fluvoxamine and sustained release theophylline in an 11-year-old boy. Drug Saf. 1991 Nov-Dec;6(6):460–462. doi: 10.2165/00002018-199106060-00006. [DOI] [PubMed] [Google Scholar]
